Lirentelimab for Severe and Chronic Forms of Allergic Conjunctivitis. Anesi SD, Tauber J, Nguyen QD, Chang P, et al. J Allergy Clin Immunol 2022 Apr 4. pii: S0091-6749(22)00442.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anesi SD, Tauber J, Nguyen QD, Chang P, et al. Lirentelimab for Severe and Chronic Forms of Allergic Conjunctivitis. J Allergy Clin Immunol 2022 Apr 4. pii: S0091-6749(22)00442.
PMID: 35390403